Clinical trials: Pregestational Diabetes Mellitus
Gestational Diabetes, Pregestational Diabetes
Permissive Intrapartum Glucose Control
The purpose of this study is to assess whether permissive intrapartum glycemic control compared to usual care would lead to similar rate of neonatal hypoglycemia among people with diabetes.
- Trial name
- NCT05553275
- Testing
- Usual Care, Permissive intrapartum glucose control
- Where
- United States
- Volunteers
- 96 people
- Sponsor
- The University of Texas Health Science Center, Houston
Type 2 Diabetes, Type 1 Diabetes
NOURISH - A Healthcare-community Partnership to Improve Nutrition for Optimal Glycemic Control and Pregnancy Outcomes With Pregestational Diabetes
Nutrition insecurity (inclusive of food insecurity + poor diet quality) is a fundamental social need that must be addressed to improve treatment and health outcomes for high-risk pregnant women with pregestational type 1 and 2…
- Conditions
- Type 2 Diabetes, Type 1 Diabetes, Pregnancy, High Risk
- Trial name
- NOURISH (NCT07560813)
- Testing
- Mid-Ohio Food Farmacy (MOF+) produce delivery, Nutrition education with Dining with Diabetes (DWD), Health Impact Ohio Central Ohio Pathways Hub to address unmet social needs
- Where
- United States
- Volunteers
- 174 people
- Sponsor
- Ohio State University
Pregestational Diabetes, Pregnancy
Once-Daily vs Twice-Daily Insulin Glargine in Pregestational Diabetes Management
The purpose of this study is to determine if taking insulin glargine twice a day instead of once a day will better manage pregestational diabetes in pregnant patients.
- Trial name
- NCT07224893
- Testing
- Use of insulin glargine once daily, Use of insulin glargine twice daily
- Where
- United States
- Volunteers
- 200 people
- Sponsor
- Eastern Virginia Medical School
Diabetes Mellitus, Type 1
Middle Cerebral and Umbilical Arteries Doppler Indices in the Prediction of Adverse Neonatal Outcome Among Diabetic Pregnant Women
120 patients will be included and divided into two groups; Control group that will include 60 healthy pregnant women and Study group that will include 60 pregestational diabetic pregnant patients which furtherly will be…
- Trial name
- NCT03915990
- Testing
- umbilical and middle cerebral artery Doppler
- Where
- Egypt
- Volunteers
- 120 people
- Sponsor
- Cairo University
Pregnancy, Diabetes
Group vs. Traditional Diabetes Prenatal Care
This study aims to use an innovative and integrated educational curriculum to deliver prenatal care and diabetes care for pre-gestational diabetic women from approximately the first trimester of pregnancy through delivery and the…
- Trial name
- NCT03080337
- Testing
- Group Care
- Where
- United States
- Volunteers
- 12 people
- Sponsor
- University of Wisconsin, Madison
Preeclampsia, Type 1 Diabetes
Urine-plasminogen as a Predictor for Development Of Preeclampsia in Pregnant Women With Type 1 Diabetes Mellitus
A tonic active epithelial Na+ channel (ENaC) in pre-eclampsia (PE) escaped normal hormonal control may offer an attractive explanatory model for the pathophysiology of established PE. The channel is activated by plasmin.
- Trial name
- NCT01821053
- Where
- Denmark
- Volunteers
- 85 people
- Sponsor
- Odense University Hospital
Pre-Gestational Diabetes, Type2diabetes
A Randomized Controlled Trial of Diabetes Screening Immediately Postpartum (DIP) and Follow Up PP CARE
DIP : To conduct a pragmatic, non-blinded randomized controlled trial (pRCT) of immediate in-patient postpartum OGTT prior to delivery discharge (intervention) versus 4-12 week outpatient postpartum OGTT (current standard care)…
- Conditions
- Pre-Gestational Diabetes, Type2diabetes, Pregnancy in Diabetic, Pregnancy, High Risk
- Trial name
- NCT05909046
- Testing
- Immediate inpatient postpartum OGTT, Standard of care 4-12 week postpartum OGTT
- Where
- United States
- Volunteers
- 104 people
- Sponsor
- Ohio State University
Gestational Diabetes, Pregestational Diabetes
Possible Epigenetic Changes in Offspring of Women With Pregestational and Gestational Diabetes
Pregestational diabetes (PGD) during pregnancy may be associated with an increased rate of spontaneous abortions, intrauterine death and congenital anomalies among the offspring.
- Conditions
- Gestational Diabetes, Pregestational Diabetes, IDM (Infant of Diabetic Mothers), Neurodevelopmental Outcome
- Trial name
- NCT01255384
- Where
- Israel
- Volunteers
- 300 people, healthy volunteers welcome
- Sponsor
- Hadassah Medical Organization
Diabetes in Pregnancy
Telocytes in Placental Tissues of Patients With Gestational and Pre-gestational Diabetes
Examining the expression of telocytes in the placental tissues and umbilical cord of patients with gestational or pregestational diabetes during pregnancy compared to control.
- Trial name
- NCT05305326
- Where
- Egypt
- Volunteers
- 60 people, healthy volunteers welcome
- Sponsor
- Sohag University
Pregestational Obesity (BMI > 27kg/m2), History of Polycystic Ovary Syndrome
Medical Nutrition Therapy Plus Transgestational Metformin For Preventing Gestational Diabetes In High Risk Mexican Women
Gestational diabetes mellitus is one of the most frequent complications of pregnancy, that affect between 1 to 14% of population around the world.
- Trial name
- NCT01675310
- Testing
- medical nutrition therapy + metformin, Medical nutrition therapy
- Where
- Mexico
- Volunteers
- 90 people
- Sponsor
- Instituto Nacional de Perinatologia Isidro Espinosa de los Reyes
Gestational Diabetes, Pregestational Diabetes
Maternal Diabetes in Newborns With Hearing Loss
This study aims to investigate the presence and characteristics of maternal diabetes as a risk factor in newborns with hearing loss. Hearing loss is one of the most common congenital anomalies among newborns.
- Conditions
- Gestational Diabetes, Pregestational Diabetes, Hearing Loss
- Trial name
- GDM (NCT05152589)
- Testing
- hearing test
- Where
- Turkey (Türkiye)
- Volunteers
- 500 people, healthy volunteers welcome
- Sponsor
- Ankara City Hospital Bilkent
Gestational Diabetes, Diabetes
The Belgian Diabetes in Pregnancy Study: BEDIP-N Study
The General hypothesis is that the IADPSG screening strategy for gestational diabetes (GDM) will lead to an important increase in the work load and the prevalence of GDM in Belgium but that this might not be cost effective…
- Trial name
- BEDIP-N (NCT02036619)
- Where
- 7 sites in Belgium
- Volunteers
- 2,006 people
- Sponsor
- Universitaire Ziekenhuizen KU Leuven
Diabetes Mellitus in Pregnancy
Efficacy of FGM in Pregestational Diabetes
Diabetes is the most common metabolic disease complicating pregnancy, and the number of women in childbearing age facing this problem is rising worldwide.
- Trial name
- FlashMom (NCT04666818)
- Testing
- Use of Flash Glucose Monitoring
- Where
- Italy
- Volunteers
- 40 people
- Sponsor
- University of Catania
Pregestational Diabetes, Continuous Glucose Monitoring
CGM Accuracy in Pregnancy Study
Pregnancy in women with diabetes remains a high-risk condition, requiring strict glycemic control due to rapid physiological changes that affect insulin sensitivity.
- Trial name
- NCT07269015
- Testing
- Dexcom One Plus, FreeStyle Libre 2 Plus, Additional Study Procedures
- Where
- Spain
- Volunteers
- 66 people
- Sponsor
- Hospital Mutua de Terrassa
Pregestational Diabetes
Intrapartum Maternal Glycemic Control Using Insulin Pump Versus Insulin Drip - Cohort Observational Trial
The purpose of this study is to compare intrapartum glycemic control using insulin pump versus intravenous (IV) insulin administration.
- Trial name
- NCT01158040
- Where
- Israel
- Volunteers
- 88 people, healthy volunteers welcome
- Sponsor
- Sheba Medical Center
Gestational Diabetes Mellitus in Pregnancy, Pregestational Diabetes Mellitus
Intrapartum Glucose Control and Risk of Neonatal Hypoglycemia
The purpose of this study is to assess whether a liberal intrapartum glycemic target range compared to usual care standard control ranges will lead to a decrease in the rate of neonatal hypoglycemia among pregnant patients in…
- Conditions
- Gestational Diabetes Mellitus in Pregnancy, Pregestational Diabetes Mellitus, Neonatal Hypoglycemia
- Trial name
- NCT06643351
- Testing
- Standard Intrapartum Glucose Target Range, Liberalized Intrapartum Glucose Target Range
- Where
- United States
- Volunteers
- 169 people
- Sponsor
- University of Pittsburgh
Gestational Diabetes, Pre-Gestational Diabetes
the Efficacy of Fetal Arterial and Venous Doppler Indices in Predicting Perinatal Outcome
To determine and evaluate the diagnostic performance of Doppler sonography of umbilical artery (UA), fetal middle cereberal artery (MCA), ductus venosus (VD) and umbilical vein (UV) for prediction of adverse perinatal outcome…
- Conditions
- Gestational Diabetes, Pre-Gestational Diabetes, IUGR, Macrosomia, Fetal
- Trial name
- NCT05410080
- Testing
- Fasting blood sugar, 2 hours postprandial, HBA1C ,Ultrasound and Doppler study
- Where
- 2 sites in Egypt
- Volunteers
- 140 people
- Sponsor
- Cairo University
Pregnancy in Diabetics, Placenta
Fetal Growth and Placental Function in Pregnancies Complicated by Diabetes
Diabetic pregnancies are often complicated by placental dysfunction with reduced transfer of oxygen from the mother to the fetus, which may compromise fetal growth and organ development.
- Conditions
- Pregnancy in Diabetics, Placenta, Fetal Growth, Magnetic Resonance Imaging
- Trial name
- FaPDi (NCT04801121)
- Where
- Denmark
- Volunteers
- 100 people, healthy volunteers welcome
- Sponsor
- Sidsel Linneberg Rathcke
Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus
Preliminary Exploration on the Operational Standards of Insulin Pump Installation in Diabetes Clinic in China
Continuous subcutaneous insulin infusion (CSII), known as insulin pump therapy, has been widely used for diabetes patients in recent years.
- Conditions
- Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus, Gestational Diabetes Mellitus, Pancreatogenic Diabetes Mellitus
- Trial name
- NCT04129424
- Testing
- Insulin pump (Microtech, Equil®)
- Where
- China
- Volunteers
- 180 people
- Sponsor
- Peking Union Medical College Hospital
Type 2 Diabetes Mellitus (T2DM), Pregnancy
CGM Adherence Compared to Finger-stick Glucose Monitoring in Pregnancies With Type 2 Pregestational Diabetes
The purpose of this study is to compare patient adherence to blood sugar monitoring during pregnancy using two different measurement methods in pregnancies complicated by pregestational type 2 diabetes (T2DM).
- Conditions
- Type 2 Diabetes Mellitus (T2DM), Pregnancy, Continuous Glucose Monitoring System
- Trial name
- PRECIOUS (NCT07184775)
- Testing
- Continuous glucose monitor, Glucometer
- Where
- 2 sites in United States
- Volunteers
- 70 people
- Sponsor
- Thomas Jefferson University